- Email: [email protected]
Human Immunology
EDITORIAL
Human
Immunology
It is my distinct pleasure to assume the role of Editorin-Chief of i%man immunology and announce the selection of a new Editorial Board reflecting the expanded scope of the journal. Since its inception twenty years ago, Hmun lnzmzmoiogy has been largely devoted to the discipline of human immunogenetics. Under the tireless leadership of Bernard Amos the journal has held an important position in communicating advances in the field to the HLA community. In the recent past, however, we have witnessed major advances in other areas of immunology, transplantation and immunity in general. New discoveries in these fields are being made at a rapid pace. The tremendous progress in the understanding of the structure and function of MHC antigens, differentiation antigens and cytokines has important implications for the management of patients with transplants or immunologic diseases. The primary goal of Human Immunology will be to provide a unifying view of new developments in Immunogenetics, Cellular, Molecular and Clinical Immunology. Section Editors for each of these broad areas have been selected to expedite the review progress. The Immunogenetics section will publish research on structural polymorphism of HLA genes in healthy and diseased populations, their function, regulation and expression in normal and malignant cells.
Human Immunology 52, iii (1997) Q American Society for Histocompatibility
and Immunogenetics,
1997
The Molecular and Structural Immunology section will publish research on the structure and function of molecules that play a role in the activation and regulation of the immune system. The Cellular Immunology section will encompass broad areas of in vitro and in viva studies of cellular immune responses in transplantation, autoimmunity and infectious diseases. The Clinical Immunology section will present studies on the immunology of solid organ and bone marrow transplantation, autoimmune, allergic and infectious diseases and anti-tumor responses. Manuscripts will be reviewed and published rapidly. Papers will be published within 8-12 weeks from acceptance of the final manuscript. The chief criteria for acceptance of articles for publication are originality and quality. Pertinent information about immunologic studies in animal systems may also be considered. Reviews, mini-reviews and occasionally meeting reviews on new developments in immunology and related topics are invited. We hope that Hmzun Immunology will become a forum for presenting new scientific advances and concepts to a wide audience. Dr. Nicole Suciu-Foca
019%8859/97/$17.00 PII SO198-8859(97)00002-7
Human
Immunology
It is my distinct pleasure to assume the role of Editorin-Chief of i%man immunology and announce the selection of a new Editorial Board reflecting the expanded scope of the journal. Since its inception twenty years ago, Hmun lnzmzmoiogy has been largely devoted to the discipline of human immunogenetics. Under the tireless leadership of Bernard Amos the journal has held an important position in communicating advances in the field to the HLA community. In the recent past, however, we have witnessed major advances in other areas of immunology, transplantation and immunity in general. New discoveries in these fields are being made at a rapid pace. The tremendous progress in the understanding of the structure and function of MHC antigens, differentiation antigens and cytokines has important implications for the management of patients with transplants or immunologic diseases. The primary goal of Human Immunology will be to provide a unifying view of new developments in Immunogenetics, Cellular, Molecular and Clinical Immunology. Section Editors for each of these broad areas have been selected to expedite the review progress. The Immunogenetics section will publish research on structural polymorphism of HLA genes in healthy and diseased populations, their function, regulation and expression in normal and malignant cells.
Human Immunology 52, iii (1997) Q American Society for Histocompatibility
and Immunogenetics,
1997
The Molecular and Structural Immunology section will publish research on the structure and function of molecules that play a role in the activation and regulation of the immune system. The Cellular Immunology section will encompass broad areas of in vitro and in viva studies of cellular immune responses in transplantation, autoimmunity and infectious diseases. The Clinical Immunology section will present studies on the immunology of solid organ and bone marrow transplantation, autoimmune, allergic and infectious diseases and anti-tumor responses. Manuscripts will be reviewed and published rapidly. Papers will be published within 8-12 weeks from acceptance of the final manuscript. The chief criteria for acceptance of articles for publication are originality and quality. Pertinent information about immunologic studies in animal systems may also be considered. Reviews, mini-reviews and occasionally meeting reviews on new developments in immunology and related topics are invited. We hope that Hmzun Immunology will become a forum for presenting new scientific advances and concepts to a wide audience. Dr. Nicole Suciu-Foca
019%8859/97/$17.00 PII SO198-8859(97)00002-7